Metabolic adaptation of skeletal muscle to high altitude hypoxia: How new technologies could resolve the controversies

Genome Medicine

Volumn 1, Issue 12, 2009, Pages

  Murray, Andrew J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MONOCARBOXYLATE TRANSPORTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BCL 2; PROTEIN BNIP3; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 4; REACTIVE OXYGEN METABOLITE; TRICARBOXYLIC ACID; UNCOUPLING PROTEIN 3; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ADAPTIVE ENVIRONMENTAL MANAGEMENT; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ANAEROBIC METABOLISM; ARTICLE; CELL FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER MODEL; HOMEOSTASIS; HUMAN; HYPOXIA; METABOLIC REGULATION; METABOLISM; METABOLOMICS; MITOCHONDRIAL VOLUME DENSITY; MUSCLE ATROPHY; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEOMICS; SEDENTARY LIFESTYLE; SKELETAL MUSCLE; TRANSCRIPTOMICS;

EID: 78650561172     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm117     Document Type: Article

References (72)

1. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001, 10:1215-1220. 10.1093/hmg/10.11.1215, 11371514.
2. Grocott M, Montgomery H, Vercueil A. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit Care 2007, 11:203. 10.1186/cc5142, 2151873, 17291330.
3. Raguso CA, Guinot SL, Janssens JP, Kayser B, Pichard C. Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care 2004, 7:411-417. 10.1097/01.mco.0000134372.78438.09, 15192444.
4. Khosravi M, Grocott M. Mountainside to bedside: reality or fiction?. Expert Rev Resp Med 2009, 3:561-565.
5. Thompson J, Raitt J, Hutchings L, Drenos F, Bjargo E, Loset A, Grocott M, Montgomery H. Angiotensin-converting enzyme genotype and successful ascent to extreme high altitude. High Alt Med Biol 2007, 8:278-285. 10.1089/ham.2007.1044, 18081503.
6. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 2000, 94:841-846. 10.1053/rmed.2000.0804, 11001074.
7. Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, Malconian MK, Rock PB, Young PM, Walter SD, Houston CS. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol 1988, 64:1309-1321.
8. Grocott MP, Martin DS, Levett DZ, McMorrow R, Windsor J, Montgomery HE. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med 2009, 360:140-149. 10.1056/NEJMoa0801581, 19129527.
9. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007, 2007:cm8. 10.1126/stke.4072007cm8, 17925579.
10. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472. 10.1126/science.1059796, 11292861.
11. Fedele AO, Whitelaw ML, Peet DJ. Regulation of gene expression by the hypoxia-inducible factors. Mol Interv 2002, 2:229-243. 10.1124/mi.2.4.229, 14993394.
12. Ferretti G. Limiting factors to oxygen transport on Mount Everest 30 years after: a critique of Paolo Cerretelli's contribution to the study of altitude physiology. Eur J Appl Physiol 2003, 90:344-350. 10.1007/s00421-003-0923-2, 14530980.
13. Howald H, Hoppeler H. Performing at extreme altitude: muscle cellular and subcellular adaptations. Eur J Appl Physiol 2003, 90:360-364. 10.1007/s00421-003-0872-9, 12898262.
14. Martinelli M, Winterhalder R, Cerretelli P, Howald H, Hoppeler H. Muscle lipofuscin content and satellite cell volume is increased after high altitude exposure in humans. Experientia 1990, 46:672-676. 10.1007/BF01939930, 2373192.
15. Zungu M, Young ME, Stanley WC, Essop MF. Expression of mitochondrial regulatory genes parallels respiratory capacity and contractile function in a rat model of hypoxia-induced right ventricular hypertrophy. Mol Cell Biochem 2008, 318:175-181. 10.1007/s11010-008-9867-5, 2673516, 18604475.
16. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008, 283:10892-10903. 10.1074/jbc.M800102200, 2447655, 18281291.
17. Zhang HM, Cheung P, Yanagawa B, McManus BM, Yang DC. BNips: a group of pro-apoptotic proteins in the Bcl-2 family. Apoptosis 2003, 8:229-236. 10.1023/A:1023616620970, 12766483.
18. Regula KM, Ens K, Kirshenbaum LA. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 2002, 91:226-231. 10.1161/01.RES.0000029232.42227.16, 12169648.
19. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007, 11:407-420. 10.1016/j.ccr.2007.04.001, 17482131.
20. Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O'Rahilly S, Montague C, Vidal-Pugh AJ. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 2003, 373:155-165. 10.1042/BJ20030200, 1223480, 12678921.
21. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003, 24:78-90. 10.1210/er.2002-0012, 12588810.
22. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801. 10.1038/nature00904, 12181572.
23. Hoppeler H, Kleinert E, Schlegel C, Claassen H, Howald H, Kayar SR, Cerretelli P. Morphological adaptations of human skeletal muscle to chronic hypoxia. Int J Sports Med 1990, 11(suppl 1):S3-9. 10.1055/s-2007-1024846, 2323861.
24. Lundby C, Pilegaard H, Andersen JL, van Hall G, Sander M, Calbet JA. Acclimatization to 4100 m does not change capillary density or mRNA expression of potential angiogenesis regulatory factors in human skeletal muscle. J Exp Biol 2004, 207:3865-3871. 10.1242/jeb.01225, 15472017.
25. Shaw RJ. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 2009, 196:65-80. 10.1111/j.1748-1716.2009.01972.x, 19245654.
26. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006, 124:471-484. 10.1016/j.cell.2006.01.016, 16469695.
27. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740. 10.1038/nature06322, 18046414.
28. Vigano A, Ripamonti M, De Palma S, Capitanio D, Vasso M, Wait R, Lundby C, Cerretelli P, Gelfi C. Proteins modulation in human skeletal muscle in the early phase of adaptation to hypobaric hypoxia. Proteomics 2008, 8:4668-4679. 10.1002/pmic.200800232, 18937252.
29. Lee WJ, Kim M, Park H-S, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim M-S, Oh GT, Yoon M, Lee K-U, Park J-Y. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1. Biochem Biophys Res Commun 2006, 340:291-295. 10.1016/j.bbrc.2005.12.011, 16364253.
30. Bonen A. PGC-1alpha-induced improvements in skeletal muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 2009, 34:307-314. 10.1139/H09-008, 19448691.
31. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508. 1052012, 15765131.
32. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006, 91:807-819. 10.1113/expphysiol.2006.033506, 16857720.
33. O'Hagan KA, Cocchiglia S, Zhdanov AV, Tambuwala MM, Cummins EP, Monfared M, Agbor TA, Garvey JF, Papkovsky DB, Taylor CT, Allan BB. PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc Natl Acad Sci USA 2009, 106:2188-2193. 10.1073/pnas.0808801106, 2632715,2632715, 19179292.
34. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122. 10.1016/j.cell.2007.01.047, 17418790.
35. Green HJ, Sutton JR, Wolfel EE, Reeves JT, Butterfield GE, Brooks GA. Altitude acclimatization and energy metabolic adaptations in skeletal muscle during exercise. J Appl Physiol 1992, 73:2701-2708.
36. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994, 269:23757-23763.
37. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 15:551-578. 10.1146/annurev.cellbio.15.1.551, 10611972.
38. Xia Y, Warshaw JB, Haddad GG. Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult rats. Am J Physiol 1997, 273:R1734-1741.
39. Silva JL, Giannocco G, Furuya DT, Lima GA, Moraes PA, Nachef S, Bordin S, Britto LR, Nunes MT, Machado UF. NF-kappaB, MEF2A, MEF2D and HIF1-a involvement on insulin- and contraction-induced regulation of GLUT4 gene expression in soleus muscle. Mol Cell Endocrinol 2005, 240:82-93. 10.1016/j.mce.2005.05.006, 16024167.
40. Bigard AX, Brunet A, Guezennec CY, Monod H. Skeletal muscle changes after endurance training at high altitude. J Appl Physiol 1991, 71:2114-2121.
41. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006, 3:177-185. 10.1016/j.cmet.2006.02.002, 16517405.
42. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006, 3:187-197. 10.1016/j.cmet.2006.01.012, 16517406.
43. De Palma S, Ripamonti M, Vigano A, Moriggi M, Capitanio D, Samaja M, Milano G, Cerretelli P, Wait R, Gelfi C. Metabolic modulation induced by chronic hypoxia in rats using a comparative proteomic analysis of skeletal muscle tissue. J Proteome Res 2007, 6:1974-1984. 10.1021/pr060614o, 17391017.
44. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006, 281:9030-9037. 10.1074/jbc.M511397200, 16452478.
45. Juel C, Lundby C, Sander M, Calbet JA, Hall G. Human skeletal muscle and erythrocyte proteins involved in acid-base homeostasis: adaptations to chronic hypoxia. J Physiol 2003, 548:639-648. 10.1113/jphysiol.2002.035899, 2342856, 12611920.
46. Zoll J, Ponsot E, Dufour S, Doutreleau S, Ventura-Clapier R, Vogt M, Hoppeler H, Richard R, Fluck M. Exercise training in normobaric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts. J Appl Physiol 2006, 100:1258-1266. 10.1152/japplphysiol.00359.2005, 16540710.
47. Simon MC. Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metab 2006, 3:150-151. 10.1016/j.cmet.2006.02.007, 16517402.
48. Young AJ, Evans WJ, Fisher EC, Sharp RL, Costill DL, Maher JT. Skeletal muscle metabolism of sea-level natives following short-term high-altitude residence. Eur J Appl Physiol Occup Physiol 1984, 52:463-466. 10.1007/BF00943381, 6540677.
49. Green HJ, Sutton JR, Cymerman A, Young PM, Houston CS. Operation Everest II: adaptations in human skeletal muscle. J Appl Physiol 1989, 66:2454-2461.
50. Howald H, Pette D, Simoneau JA, Uber A, Hoppeler H, Cerretelli P. Effect of chronic hypoxia on muscle enzyme activities. Int J Sports Med 1990, 11(suppl 1):S10-14. 10.1055/s-2007-1024847, 2323857.
51. Johnson AB, Denko N, Barton MC. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat Res 2008, 640:174-179. 2346607, 18294659.
52. West JB. Lactate during exercise at extreme altitude. Fed Proc 1986, 45:2953-2957.
53. Lundby C, Saltin B, van Hall G. The 'lactate paradox', evidence for a transient change in the course of acclimatization to severe hypoxia in lowlanders. Acta Physiol Scand 2000, 170:265-269. 10.1046/j.1365-201x.2000.00785.x, 11450136.
54. van Hall G, Calbet JA, Sondergaard H, Saltin B. The re-establishment of the normal blood lactate response to exercise in humans after prolonged acclimatization to altitude. J Physiol 2001, 536:963-975. 10.1111/j.1469-7793.2001.00963.x, 2278893, 11691888.
55. van Hall G, Lundby C, Araoz M, Calbet JA, Sander M, Saltin B. The lactate paradox revisited in lowlanders during acclimatization to 4100 m and in high-altitude natives. J Physiol 2009, 587:1117-1129. 10.1113/jphysiol.2008.160846, 19139048.
56. Van Patot, M.C.T. , Murray, A.J., Beckey, V., Cindrova-Davies, T., Johns, J., Zwerdlinger, L., Jauniaux, E., Burton, G.J.b, Serkova, N.J., Human placental metabolic adaptation to chronic hypoxia, high altitude: Hypoxic preconditioning, American Journal of Physiology - Regulatory Integrative and Comparative Physiology(2010), 298(1), Pages R166-R172, DOI: 10.1152/ajpregu.00383.2009
57. Hinkle PC, Kumar MA, Resetar A, Harris DL. Mechanistic stoichiometry of mitochondrial oxidative phosphorylation. Biochemistry 1991, 30:3576-3582. 10.1021/bi00228a031, 2012815.
58. Narravula S, Colgan SP. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol 2001, 166:7543-7548.
59. Gilde AJ, van Bilsen M. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol Scand 2003, 178:425-434. 10.1046/j.1365-201X.2003.01161.x, 12864748.
60. Huss JM, Levy FH, Kelly DP. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid × receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 2001, 276:27605-27612. 10.1074/jbc.M100277200, 11371554.
61. Essop MF, Razeghi P, McLeod C, Young ME, Taegtmeyer H, Sack MN. Hypoxia-induced decrease of UCP3 gene expression in rat heart parallels metabolic gene switching but fails to affect mitochondrial respiratory coupling. Biochem Biophys Res Commun 2004, 314:561-564. 10.1016/j.bbrc.2003.12.121, 14733944.
62. Aragones J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008, 40:170-180. 10.1038/ng.2007.62, 18176562.
63. Ou LC, Leiter JC. Effects of exposure to a simulated altitude of 5500 m on energy metabolic pathways in rats. Respir Physiol Neurobiol 2004, 141:59-71. 10.1016/j.resp.2004.04.001, 15234676.
64. Lu Z, Sack MN. ATF-1 is a hypoxia-responsive transcriptional activator of skeletal muscle mitochondrial-uncoupling protein 3. J Biol Chem 2008, 283:23410-23418. 10.1074/jbc.M801236200, 2517006, 18579531.
65. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, Harper JA, Roebuck SJ, Morrison A, Pickering S, Clapham JC, Brand MD. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415:96-99. 10.1038/415096a, 11780125.
66. Gnaiger E, Mendez G, Hand SC. High phosphorylation efficiency and depression of uncoupled respiration in mitochondria under hypoxia. Proc Natl Acad Sci USA 2000, 97:11080-11085. 10.1073/pnas.97.20.11080, 27151, 11005877.
67. Gore CJ, Clark SA, Saunders PU. Nonhematological mechanisms of improved sea-level performance after hypoxic exposure. Med Sci Sports Exerc 2007, 39:1600-1609. 10.1249/mss.0b013e3180de49d3, 17805094.
68. Lundby C, Calbet JA, Sander M, van Hall G, Mazzeo RS, Stray-Gundersen J, Stager JM, Chapman RF, Saltin B, Levine BD. Exercise economy does not change after acclimatization to moderate to very high altitude. Scand J Med Sci Sports 2007, 17:281-291.
69. Mogensen M, Bagger M, Pedersen PK, Fernstrom M, Sahlin K. Cycling efficiency in humans is related to low UCP3 content and to type I fibres but not to mitochondrial efficiency. J Physiol 2006, 571:669-681. 10.1113/jphysiol.2005.101691, 1805795, 16423857.
70. Noble D. The Music of Life: Biology Beyond the Genome 2006, Oxford: Oxford University Press.
71. Beard DA, Bassingthwaighte JB, Greene AS. Computational modeling of physiological systems. Physiol Genomics 2005, 23:1-3. discussion 4., 10.1152/physiolgenomics.00117.2005, 16179418.
72. Grocott M, Richardson A, Montgomery H, Mythen M. Caudwell Xtreme Everest: a field study of human adaptation to hypoxia. Crit Care 2007, 11:151. 10.1186/cc5921, 2206524, 17672886.